Preventing disease by protecting the cervix: The unexplored promise of internal vaginal barrier devices

AIDS

Volumn 15, Issue 13, 2001, Pages 1595-1602

  Moench, Thomas R ^a   Chipato, Tsungai ^b   Padian, Nancy S ^c  

^a REPROTECT INC   (United States)

^b UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervix; Diaphragms; HIV; Microbicides; Sexually transmitted disease; Susceptibility; Women

Indexed keywords

CONTRACEPTIVE DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX; VIRUS TRANSMISSION;

ANTI-INFECTIVE AGENTS, LOCAL; CERVIX UTERI; CONDOMS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; SEXUALLY TRANSMITTED DISEASES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0035822950     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200109070-00001     Document Type: Review

References (66)

1. Family planning, sexually transmitted diseases and contraceptive choice: A literature update-Part II
2. Editorial: HIV prevention: An update on the status of methods women can use
3. Editorial: The double bind in science policy and the protection of women from HIV infection
4. WHO widens focus of AIDS research
5. The doctor's world: New strategy backed for fighting AIDS
6. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections
7. Factors related to genital chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic
8. Barrier contraceptives and sexually transmitted diseases in women: A comparison of female-dependent methods and condoms
9. A case-control study of spermicides and gonorrhea
10. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections
11. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases
12. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
13. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers
14. Barrier contraceptive use and HIV infection among high-risk women in Cameroon
15. Advances in topical microbicides
16. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials
17. Chlamydia trachomatis infections of the adult
18. Gonococcal infections in the adult
19. Cervical neoplasia and other STD-related genital tract neoplasias
20. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women
21. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use
22. Barrier-method contraceptives and pelvic inflammatory disease
23. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
24. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract
25. Herpes simplex virus
26. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks
27. Sensitive method for the detection of infectious HIV in semen of seropositive individuals
28. Quantification of HIV in semen: Correlation with antiviral treatment and immune status
29. HIV-1 infection among heterosexual attenders at a sexually transmitted diseases clinic in Durban
30. Rising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: Traumatic sex and genital ulcers as risk factors
31. The effect of number of exposures on the risk of heterosexual HIV transmission
32. Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil
33. IL-1beta, IL-6, TNF-alpha, fetal fibronectin, and endotoxin in the lower gential tract of pregnant women with bacterial vaginosis
34. The global HIV/AIDS epidemic
35. Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: Results of a study of couples in Nairobi, Kenya
36. Adolescents and STDs
37. Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking and douching
38. Biological behavior and etiology of inflammatory cervical smears
39. Pelvic inflammatory disease
40. Sperm transport from the external cervical as to the fallopian tubes in women: A time and quantitation study
41. The transport of carbon particles in the human female reproductive tract
42. Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women
43. The dynamics of rapid sperm transport through the female genital tract. Evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy
44. Uterine contractility and the ascent of vaginal contents into the uterus
45. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases
46. Expression of chemokine receptors in human reproductive tissues
47. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
48. Repertoire of chemokine receptor expression in the female genital tract: Progesterone increases CCR5 CXCR4 and CCR3 expression
49. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia
50. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells
51. Mucosal transmission of simian immunodeficiency virus
52. Heterosexual transmission of human immunodeficiency virus: Association with severe depletion of T-helper lymphocytes in men with hemophilia
53. Genital infection of female chimpanzees with human immunodeficiency virus type 1
54. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth
55. The cat/FIV model for transmucosal transmission of AIDS: Nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum
56. Is the diaphragm a viable option for women in Turkey?
57. Accetpiblity of the diaphragm among low-income women in Sao Paula, Brazil
58. A comparative study of the safety and efficacy of FemCap®, a new vaginal barrier contraceptive, and the Ortho All-Flex® diaphragm
59. Short-term acceptability of the female condom among staff and patients at a New York City Hospital
60. Long-term use of the female condom among coupes at high risk of human immunodeficiency virus infection in Zambia
61. Dynamics of female condom acceptability among prostitutes and young women in Abidjan, Ivory Coast
62. Pelvic inflammatory disease: The influence of contraceptive, sexual, and social life events